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Abstract
Regulation of gene expression by microRNAs (miRNAs) is now considered as an essential mechanism for cell development
and homeostasis. Indeed, numerous studies have reported that modulating their expression, maturation, or activity can
affect cell survival, identity or activation. In particular, miRNAs are key players in the tight regulation of signaling cascades,
and as such, they appear as perfectly suited immunomodulators. Several immune-related processes, including
inflammation, have recently been demonstrated to require specific miRNAs. In addition, the discovery of herpesvirus-
encoded miRNAs has reinforced this assumption. To decipher the potential roles of miRNAs in innate antiviral immune
response, we developed an in vivo model based on the inoculation of mouse cytomegalovirus (MCMV) in mice.
Furthermore, we exploited a mouse line carrying a hypomorphic mutation in the Dicer gene to visualize the impact of
impaired miRNA biogenesis upon the anti-MCMV response. Our data indicate that miRNAs are important actors in mounting
an efficient response against herpesviruses. We suggest that a rapid and transient interferon response following viral
infection requires miRNA-dependent repressor release. In addition, our in vivo efforts identified several miRNA targets, thus
providing a conceptual framework for future analyzes on the regulation of specific actors involved in the Type I interferon
pathway.
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Introduction
MicroRNAs (miRNAs) are short (22-nt long) non coding RNAs,
which are essential regulators of gene expression in multicellular
organisms [1]. Many reports have led to the description of a now
well-defined pathway whereby genes encoding miRNAs, following
RNA polymerase II-mediated transcription, give rise to long
primary precursors (pri-miRNAs) that are processed by the
nuclear RNase III Drosha. The resulting precursor molecules
(pre-miRNAs), which adopt a stem-loop structure, are then
exported to the cytoplasm where they are processed by another
RNase III (Dicer) to generate double-stranded miRNA interme-
diates. One strand of this duplex is then incorporated into an
Argonaute-containing RNA-induced silencing complex (RISC),
resulting in the translational repression and/or degradation of
their target mRNAs [2]. Recent data indicate that vertebrates
express several hundred miRNAs (741 in Mus musculus, 1527 in
Homo sapiens) [3], each of which can potentially regulate tens to
hundreds of target genes. Therefore, the current model stipulates
that miRNAs are major modulators of gene expression, and
estimates indicate that as many as 60% of all human genes are
subject to miRNA-mediated post-transcriptional regulation [4,5].
It is now widely recognized that cellular miRNAs are implicit in
the regulation of many physiological processes, including embry-
onic development, and the tight homeostasis of immune cells [1].
Furthermore, it is also clear that their misexpression can lead to
inappropriate responses to external stimuli such as viruses. Indeed,
it was reported in several instances and using different experi-
mental models, that blocking specific miRNAs or decreased
miRNA production leads to impaired antiviral defense [6,7].
Further complexity was unveiled following the discovery of virus-
encoded miRNAs in the genomes of large DNA viruses such as
herpesviruses [8,9,10].
To analyze the contribution of miRNAs to host defense against
herpesviruses, we used a model system, namely the experimental
infection of mice by murine cytomegalovirus (MCMV), which has
previously proved its reliability to study innate antiviral mecha-
nisms such as, for example, Toll-like receptor signaling [11,12,13].
We also took advantage of the availability of a mouse strain that
carries a hypomorphic mutation in the Dicer gene to manipulate
miRNA production. This mouse strain enables the analysis of the
consequences of reduced Dicer expression in every cell of the
animal, as opposed to a targeted deletion in specific tissues using
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the Flox/Cre system. Using this mutant mouse, it was previously
shown that cellular miRNAs play an important role in the defense
against vesicular stomatitis virus (VSV) [6]. Here, we further
developed this murine model to decipher the complex host-
pathogen interaction during acute MCMV infection. We per-
formed both in vivo acute infection and ex vivo infection of primary
macrophages followed by a global analysis of interferon (IFN)-
dependent gene expression and quantification of miRNAs
involved in inflammation/immune processes. Altogether, our data
identified biologically relevant miRNA-targeted IFN-stimulated
genes. Our data suggest that repressor release is an important
event for the rapid transcriptional induction of MCMV-induced,
IFN-mediated genes. Furthermore, our results point toward a
dominant role of cellular miRNAs as protective factors compared
to viral miRNAs, which are usually predicted to carry pathogenic
functions.
Materials and Methods
Mice
Dicer1-deficient mice (Dicerd/d) were generated by Jiahuai Han’s
laboratory and described in [6]. The Dicerd/d line was backcrossed
more than 10 times against C57BL/6 in our laboratory; littermate
controls are indicated by +/+ in all figures. Mice used in all
experiments were age- and sex-matched. Animals were main-
tained under pathogen-free conditions in the animal care facility of
the Institut d’Immunologie et d’He´matologie.
Ethic statement
Handling of mice and experimental procedures were conducted
in accordance with the French Law for the Protection of
Laboratory Animals. The procedures were approved by the
service ve´terinaire de la Pre´fecture du Bas-Rhin (France) under the
authorization number A-67-345 and reviewed by the Regional
Ethical Committee for Animal Experimentation (CREMEAS) of
the Strasbourg University.
Cell culture
To harvest peritoneal macrophages, mice were injected
intraperitoneally (i.p.) with 3% thioglycolate (TG). After 3 days,
peritoneal exudates were harvested in 5 ml of PBS. After
centrifugation, cells were suspended in DMEM (Gibco) supple-
mented with 5% FCS and 2% penicillin-streptomycin. Cells were
plated at 26106 cells per well (6 well plates) and incubated at 37uC
in a 5% CO2 atmosphere. After removal of non-adherent cells,
adherent cells were washed with PBS and infected at the indicated
multiplicity of infection (MOI).
Viruses
The Perth strain of MCMV was a salivary gland-passaged virus
stock prepared in BALB/c mice. MCMV was titrated by plaque
assay on M2-10B4 cells and was injected intra peritoneally (i.p.) to
mice at doses of 56105 p.f.u/mouse.
The Smith strains of MCMV expressing Luciferase (MCMV-
Luc) or Cre (MCMV-Cre), a kind gift of Ulrich Koszninowski,
were obtained by BAC mutagenesis and amplified in M2-10B4
cells [14]. MCMV-Luc was injected i.p. at 56104 p.f.u/mouse.
IFN PCR array
Total RNA was extracted from approximately 46106 peritoneal
macrophages or spleens with RNeasy mini kits (Qiagen) with
inclusion of a DNase I treatment step. RNA quality was verified by
Agilent 2100 Bioanalyzer profiles.
cDNA was prepared from 1 mg (macrophages) or 2 mg (spleen)
of total RNA by using a RT2 PCR array first strand kit.
Quantitative real time PCR was performed with an ABI PRISM
7000 using Mouse Interferon a, b Response RT2 Profiler PCR
array (Qiagen, SA biosciences) according to the manufacturer’s
instructions. Complete datasets are available upon request.
miRNA array
Total RNA was extracted using miRNeasy mini kits (Qiagen,
Courtaboeuf, France). cDNA was prepared from 1 mg (macro-
phages) or 4 mg (spleen) of total RNA using a RT2 miRNA First
Strand Kit. Quantitative real time PCR was performed with an
ABI PRISM 7000 using Mouse Immunopathology RT2 miRNA
PCR array (Qiagen, SA biosciences) according to the manufac-
turer’s instructions. Datasets are available upon request.
Quantitative RT-PCR
Total RNA was isolated from different tissues using either
TRIZOL (Invitrogen), or RNeasy Mini Kit with inclusion of a
DNase I treatment step (Qiagen). After reverse transcription of
1 mg of total RNA by ImProm-IITM Reverse Transcriptase
(Promega), quantification was performed with an ABI PRISM
7000 (Applied Biosystems) using FastStart Universal SYBR Green
Master (ROX) (Roche Molecular Diagnostics, Meylan, France).
The PCR parameters were as follow: 2 min at 50uC, 10 min at
95uC followed by 40 cycles of denaturation at 95uC for 15 s, and
annealing and extension at 60uC for 1 min. Amplification was
performed in a final volume of 20 ml, and each sample contained
2 ml cDNA (equivalent to 10ng of RNA), 500 nM of forward and
reverse primers and 10 ml of FastStart Universal SYBR Green
Master (ROX) (Roche Molecular Diagnostics). Each quantitative
PCR reaction was performed in triplicate, and the mean Ct value
for each sample was used for data analysis. Samples were
normalized to b-actin, results are expressed as fold changes of
Ct values relative to controls by using the 2-DDCt formula.
Primers used were the following:
dicer 24 F: 59 AGAACGAAATGCAAGGAATGGA
dicer 25 R: 59 CTTCTTTCTCCTCATCCTCCTCG
Amplicon size: 65 bp
irf7 F: 59 CCCATCTTCGACTTCAGCAC
irf7 R: 59 TGTAGTGTGGTGACCCTTGC
Amplicon size: 79 bp
actin F: 59 AGAGGGAAATCGTGCGTGAC
actin R: 59 CAATAGTGATGACCTGGCCGT
Amplicon size: 139 bp
cxcl10 F: 59 CTGCTGGGTCTGAGTGGGACT
cxcl10 R: 59 CCTATGGCCCTCATTCTCACTG
Amplicon size: 101 bp
isg20 F: 59 GAACATCCAGAACAACTGGCG
isg20 R: 59 GTAGAGCTCCATTGTGGCCCT
Amplicon size: 67 bp
ifit1 F: 59 CAACTGAGGACATCCCGAAACA
iIfit1 R: 59 ATGTGGGCCTCAGTTTCAAAGT
Amplicon size: 109 bp
oas1a F: 59 CCAAGGTGGTGAAGGGTGG
oas1ar: 59 ACCACCAGGTCAGCGTCTGA
Amplicon size: 73 bp
microRNA in Innate Defense against Cytomegalovirus
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PRIMER EXPRESS software Applied Biosystems) was used to
design the primers.
Absolute Quantitative PCR of MCMV genome
DNA was extracted from different tissues using the phenol-
chloroform method. Primers cmv IE1 F (59-ACTAGAT-
GAGCGTGCCGCAT) and mcmv IE1 R (59-TCCCCAGG-
CAATGAACAATC) were chosen to amplify a segment of exon 4
of the IE1 gene of MCMV, and a cellular gene (encoding Zinc-a1
glycoprotein, zag) was detected with primers zag Forw.
(5’TTCAGGGAATGTTTGGTTGCG) and zag Re-
v.(59TGAAATCCTCTCCGTCGTAGGC). Serial dilutions of
pGEM-Teasy (Promega) expressing MCMV ie3/4, and of pCR2
expressing zag [15] were used as standards to determine the
MCMV genome copy number, and the number of cells
respectively. No-template controls, and DNA from uninfected
mice served as negative controls. The PCR parameters were as
above except that 100 ng of DNA was used as template. Mean Ct
values were used for data analysis; n = 3.
Northern blot analysis of miRNAs
Northern blotting of miRNAs was performed as described
previously [16] using 2 mg of total RNA and radiolabeled antisense
oligodesoxyribonucleotides complementary to miR-16, miR-M23-
2 or part of U6 snRNA as probes. Northern blots were exposed
overnight to phosphorimager plates (Fuji) and scanned using a
FLA-5000 series phosphorimager (Fuji).
Cell lysis and immunoblotting procedures
Tissues were homogenized (Omni Tissue Master) and proteins
were isolated in lysis buffer (150 mM NaCl, 50 mM Tris–HCl,
pH 8, 0.5 mM EDTA, 1% NP-40, 10% glycerol) supplemented
with complete protease inhibitor (Roche Applied Science) and
sodium orthovanadate (1 mM) (Sigma). Lysates were incubated on
ice for 20 min followed by centrifugation at 4uC for 15 min at
13,000 rpm; supernatants were kept at 220uC for further analysis.
Total protein concentration was determined using the Bradford
Assay (Bio-Rad). Samples (40 mg) were mixed with Laemmli
buffer, boiled for 5 min, and then separated on a 10%
polyacrylamide gel (Bio-Rad) followed by semi-dry blotting onto
Hybond-C Extra membranes (Amersham Pharmacia Biotech).
Proteins were revealed with anti-GAPDH (Millipore), anti-IRF7,
anti-Stat1a p91 (Santa-Cruz Biotechnology) using an HRP-goat
anti-mouse or HRP-goat anti-rabbit IgG (H + L) (Bio-Rad) as
secondary antibodies. Blots were developed with the ECL system
(Amersham Pharmacia Biotech).
Quantification of cytokines
IFN-b or CXCL10 in serum and cell supernatants were
measured with Mouse Interferon Beta ELISA Kit (PBL Inter-
feronSource) and Mouse CXCL10 ELISA kit (R&D Systems)
following the manufacturer’s instructions.
Flow cytometry
Spleen cell suspensions were incubated 2 h with brefeldin A
(10 mg/ml) before staining with FITC-conjugated anti-NKp46
(R&D Systems). For intracellular staining, cells were fixed and
incubated with PE-conjugated anti-IFN-c (BD Pharmingen). Flow
cytometry was performed by using a FACSCalibur flow cytometer
(BD Biosciences) and analyzed with Cellquest Software.
Luciferase reporter constructs
To generate luciferase-based reporter plasmids, psiCHECK-2
(Promega) was modified by inserting the Gateway cassette C.1
(Invitrogen) at the 39 end of the firefly luciferase gene (f-luc) into
the Xba I site of psiCHECK-2. The 39 untranslated region (UTR)
of Cxcl10 was amplified from NIH-3T3 genomic DNA. After
PCR addition of attB1 and 2 sequences, the resulting products
were cloned into pDONR/Zeo and then recombined in the
modified psiCHECK-2 vector using Gateway technology (Invitro-
gen). The following primer sequences were used (sense and
antisense primers are indicated in this respective order; anchor
sequences used for the nested PCR are underlined):
Cxcl10: 59 AAAAAGCAGGCTTCCGCTCAATA-
CAGTTTCCTC
and 59 AGAAAGCTGGGTCTACCCACCCCAACTTCTTG
attB1/2: 59 ACAAGTTTGTACAAAAAAGCAGGCT
and 59 ACCACTTTGTACAAGAAAGCTGGGT.
Mutagenesis of the predicted miR-21 binding site was
performed as described previously [17] using mutagenesis primers
as follows (the mutated nucleotides are underlined):
Sense: 59 TCCTAGCTCTGTACTGTATCGTATGTG-
GAGGTGCGACGC 39
Antisense: 59 GCGTCGCACCTCCACATACGATACAGTA-
CAGAGCTAGGA 39.
Transfections and luciferase assay
HeLa cells (2.56104) were seeded in 48-well plates in antibiotic-
free medium with tiny LNA inhibitors (1 mM) against miR-21, or
to that of a negative control miRNA (cel-miR-67). Transfections
were performed following 24 h of treatment using 0.5 ml
Lipofectamine 2000 (Invitrogen), and 50 ng dual luciferase
reporter plasmids. At 48 h post transfection, cells were washed
with PBS and lyzed in 65 ml of Passive Lysis Buffer (Promega).
Firefly and Renilla luciferase activities were measured from 10 ml
of each lysate using the dual luciferase reporter Assay System
(Promega) and a luminometer (Glomax, Promega).
In vivo luminescence assay
Eight hours after intraperitoneal MCMV-Luc infection, animals
were anesthetized (10 mg/ml ketamine and 2 mg/ml xylazine),
hairs were removed by chemical depilation, and mice received a
first i.p. injection of Luciferine (150 mg/kg body weight).
Luminescence was quantified using the In Vivo Imaging System
(IVIS) from Xenogen/Caliper. Afterwards, similar Luciferin
injections and light emission recording were performed at Days
1, 2, 3 and 4. Luminescence was expressed as a percentage to that
quantified 8 hours post-infection.
Statistical analysis
Student’s t (two-tailed unpaired) test was used to compare two
independent groups using GraphPad software. A probability (p)
value of , 0.05 was considered to be significant. *p , 0.05; **p ,
0.01; ***p , 0.001.
LogRank test was used for statistical analysis of survival
experiments.
Results
1. A subset of Type I IFN-regulated genes is
overexpressed in Dicer-deficient splenocytes and
macrophages
Because a well-coordinated Type I IFN response is mandatory
for mounting an efficient antiviral defense, we first undertook a
microRNA in Innate Defense against Cytomegalovirus
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thorough characterization of this pathway in control and Dicerd/d
animals under steady-state (non-infected) conditions. During its
initial characterization, the Dicerd/d mutant was shown to be
hypersusceptible to vesicular stomatitis virus (VSV) infection,
independently from Type I IFN perturbation [6]. However, only a
few elements (i.e. IFN-b production) of this response were
monitored, and since then, miRNA-dependent expression of
several genes involved in the IFN pathway has been reported.
Therefore, a comprehensive analysis of this signaling cascade
appeared necessary. To this end, we used a commercial PCR
macroarray to follow the expression pattern of a panel of 84 genes
involved in the IFN pathway at several levels: signaling molecules,
receptors, signal transduction and target genes. Interestingly, we
observed augmented expression of many (22/84; 26%) genes in
Dicerd/d splenocytes compared to control cells (Fig. 1A). In contrast,
only 6 genes were downregulated in mutant cells. We replicated
this analysis in peritoneal macrophages (a more homogenous cell
population than splenocytes), and observed that a larger (43%)
proportion of IFN-related genes were upregulated (Fig. 1B).
Looking more carefully at the complete gene list in both
systems, we noticed that the transcription of only 8 genes (Table 1)
was significantly upregulated (p,0.05) in mutant splenocytes.
Among these, Irf7, Cxcl10, Oas1a and Oas2 were also upregulated
in macrophages. To confirm the upregulation of these candidate
genes, we performed an independent qRT-PCR analysis on
mRNA extracted from spleens and macrophages from additional
wild-type and Dicerd/d mice. As shown in Figure 1C–F, statistically
significant increases in expression were observed in every case,
validating our macroarray data. We also analyzed the expression
of Dicer in these samples to verify that the previously described
mutation actually lowers its accumulation. We found that Dicer
mRNA was strongly downregulated (up to 80%) in both Dicerd/d
spleen cells and macrophages. Low Dicer expression in mutants
compared to wild-type was observed in every organ tested (lungs,
brain, salivary glands; data not shown). These observations were
Figure 1. Dicer-deficient mice exhibit constitutive up-regulation of IFN-stimulated genes in splenocytes. A. Scatterplot illustrating
macroarray data performed on mRNA from non-infected (NI) spleens harvested from control mice (+/+) or Dicerd/d mutants. Red dots indicate up-
regulated genes in mutants, whereas green dots represent down-modulated genes. B. Repartition of up-regulated genes (red), down-regulated
(green), or whose expression remains similar in Dicerd/d splenocytes and macrophages compared to controls (blue). C–F. qRT-PCR experiments on
selected IFN-dependant genes performed on mRNA extracted from control (+/+) or mutant (Dicerd/d) spleens.
doi:10.1371/journal.pone.0043744.g001
Table 1. Significantly induced genes in Dicerd/d splenocytes.
Genes Fold p value
Cxcl10 1.4832 0.042309
Gbp1 1.387 0.000552
Ifit1 2.7934 0.00814
Ifitm1 1.7435 0.024338
Irf7 2.5823 0.016564
Irf9 1.3806 0.039564
Oas1a 2.6982 0.004392
Oas2 2.9869 0.023864
doi:10.1371/journal.pone.0043744.t001
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confirmed at the protein level by western blot from whole spleen
isolates (not shown).
2. MicroRNA profiling in splenocytes from naı¨ve Dicerd/d
mice shows specific miRNA alteration
Having identified several Dicer-dependent candidate genes in
the IFN pathway, we next monitored the expression profile of
miRNAs known to be associated with inflammatory/immune
processes from the literature. We monitored 88 such miRNAs
spotted on a commercial PCR macroarray. As can be seen in
Fig. 2A, we observed a reduction in miRNA expression in
splenocytes of Dicerd/d mutants. Interestingly however, only 40% of
the tested miRNAs were affected by the mutation (downregulated
by at least 30%). Despite a very significant alteration of Dicer
expression, the amount of most (60%) miRNAs remained similar
(6 1.3 fold) in Dicer mutant splenocytes (Fig. 2C). The proportion
of miRNAs presenting a significantly decreased expression is
slightly more important (55%) in macrophages (Fig. 2B–C).
To validate our macroarray data, we performed qRT-PCR on
selected miRNAs (Fig. 2D). These experiments confirmed that the
expression of highly affected miRNAs (such as miR-98) is indeed
significantly reduced (80%) in Dicerd/d spleen cells. From the PCR
array data, we extracted a list of miRNAs whose expression was
repressed .1.5– fold in mutant spleen cells (Table 2). Remarkably,
we observed that many miRNAs within that list, were also
predicted by the miRanda program [18] to target the mRNAs
showing significantly increased expression (listed in Table 1). Thus,
Cxcl10 and miR-210, miR135a/b, or Oas2 and miR-7d, miR-
140, miR-98, let-7f, displayed opposite regulation in Dicer mutant
cells, and may be involved in the same networks in vivo. In addition
to Cxcl10 and Oas2, Ifit1 and Gbp1 could also be direct targets of
miRNAs that are listed in Table 2. Other upregulated genes such
as Irf7 possess a very short 3’UTR, which is incompatible with
miRNA targeting, unless they contained binding sites within their
coding sequences, which we have not explored. In addition, none
of the miRNAs predicted to regulate Irf9, Oas1a or IfitM1
mRNAs (i.e. miR-20, 223, 2106a) exhibited noticeable down-
regulation in Dicerd/d splenocytes. Therefore, we hypothesized that
a miRNA-dependent transcriptional regulator might represent a
common signature to these genes that would explain their
coordinated overexpression. In order to identify such a factor,
we used the SABiosciences’ proprietary database (DECODE,
DECipherment Of DNA Elements) to search for binding sites for
the most relevant transcription factors in the promoters of the
corresponding human genes (for which data on transcriptional
Figure 2. Impaired maturation of a subset of miRNAs in Dicerd/d mutant splenocytes and macrophages. A. Scatterplot showing relative
expression of miRNAs by macroarray. In red, are shown miRNAs up-regulated in naı¨ve (NI) splenocytes from Dicerd/d mutants and green depicts
down-regulated miRNAs. B. Scatterplot obtained upon macroarray analysis of mRNA extracted from control (+/+) and Dicerd/d non-infected
macrophages. C. Repartition of miRNAs down-regulated (green) or with similar expression (blue) in mutant splenocytes and macrophages. D. qRT-
PCR experiments on selected miRNAs were performed on miRNA isolated from control (+/+, dark bars) and Dicerd/d mutant (white bars) spleens.
doi:10.1371/journal.pone.0043744.g002
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regulation are more abundant and curated compared to mouse
genes). We found that the four above-mentioned genes contain
binding motifs for STAT1 in their promoters. To get an insight
into the validity of this prediction, we compared the expression
pattern of all genes spotted on the macroarray according to their
potential STAT1-dependence. A highly significant difference (p ,
0.0006) was observed when we plotted and compared the fold
regulation of STAT1-dependent genes vs. STAT1-independent
genes (Fig. S1). In parallel, we compared fold induction of genes
containing, or lacking, binding sites for an unrelated transcription
factor, AP1, in their promoters; the 2 groups appeared statistically
undistinguishable (data not shown). This indicates that Stat1
mRNA could be controlled in a miRNA-dependent manner, and
indeed, the miRanda algorithm predicts potential binding sites in
its 3’ UTR for numerous miRNAs including miR-214, miR-194
and miR-140, which are listed in Table 2. An alternative
hypothesis for differential gene expression in Dicerd/d splenocytes
compared to wild-type could reside in a modification in the
proportion of the cellular content if this organ. However, we do
not favor this option because our quantification by flow cytometry
of different splenic cell populations (NK, Dendritic cells, CD8+
and CD4+ T cells) did not reveal marked changes between
controls and mutants (not shown).
3. Potential target validation at the protein level
Because miRNAs typically regulate translation in animal cells,
we compared CXCL10 and STAT1 protein levels in both control
and Dicerd/d animals and cells. We first quantified the expression of
circulating CXCL10 in the blood of naı¨ve mice by ELISA, and
observed a significant (p,0.01) increase in CXCL10 expression (2-
fold) in serum harvested from Dicerd/d mice (Fig 3A). We also
monitored CXCL10 secretion in supernatants from primary
splenocytes, and observed increased chemokine production by
mutant cells (Fig. 3B). To evaluate STAT1 expression levels, we
performed western blots on total protein extracted from control
and Dicerd/d spleens. As shown in Fig 3C, STAT1 protein is
overexpressed in mutant spleens compared to wild-type controls,
an observation confirmed in several animals (Fig. 3D). Altogether,
these data, in conjunction with mRNA and miRNA macroarray
profiling suggests that both Cxcl10 and Stat1 mRNAs are
subjected to miRNA-dependent regulation in vivo. Quantification
of Stat1 (one of the 84 genes tested on the array) mRNA was
performed in the course of our macroarray experiments.
Interestingly, no significant difference was noticed when we
compared wild-type and mutant cells (splenocytes or macrophag-
es), indicating that miRNA-dependent STAT1 expression is
mostly controlled at the translational level.
4. Cxcl10 is a direct miRNA target
To demonstrate direct involvement of miRNAs in the control of
Cxcl10 expression, we turned to a luciferase reporter assay. As
stated above, the miRanda algorithm predicted binding sites for
numerous miRNAs, including miR-210 and miR-135a/b. How-
ever, the TargetScan algorithm [19] only predicted binding sites
for members of the miR-16 and miR-21 families. In order to
confirm that miRNAs are indeed regulating Cxcl10 expression, we
decided to focus on miR-21, which is abundantly expressed in the
cells (HeLa) we used for luciferase reporter assay. In addition, the
putative binding site of miR-21 is more extensive than the miR-16
one as assessed using RNAhybrid [20] (Fig. 3E). Finally, we
observed a 2-fold reduction of miR-21 expression in Dicerd/d
mutant compared to wild-type splenocytes (Fig. 3F). We thus
constructed a luciferase sensor for Cxcl10 by inserting its full
length 39UTR downstream of the firefly luciferase coding
sequence within the psiCHECK-2 plasmid. As a positive control,
we also constructed a reporter containing a perfectly matched
miR-21 binding site downstream of f-luc. We co-transfected these
constructs, or a plasmid containing no insert, in HeLa cells
together with tiny LNA oligonucleotides [21] designed to base-pair
with the seed of miR-21 or to that of a control miRNA (cel-miR-
67). We found that the perfect match sensor, and the Cxcl10
sensor were up-regulated two and 1.5-fold respectively in the
presence of the tiny LNA directed against miR-21 (Fig. 3G).
Insertion of a three-nucleotide bulge within the predicted miR-21
seed-match in the Cxcl10 sensor abolished this effect.
These data suggest that the Cxcl10 mRNA can be directly
targeted for post-transcriptional regulation by miR-21. It remains
of course possible that other miRNAs, such as miR-210, miR-
135a/b or miR-16, could also be involved in the regulation of this
chemokine.
5. Dicerd/d mice exhibit hypersusceptibility to acute
MCMV infection
To evaluate the impact of reduced Dicer expression on immune
responses directed against herpesviruses, we next performed acute
MCMV infection of control (+/+) and Dicerd/d mutant mice by
injecting intraperitonally 56105 p.f.u of virus, and monitoring the
survival rate of the animals. We initially expected that the
constitutively moderate increase in Type I IFN signaling of the
Dicer mutant would improve antiviral defense. We were therefore
surprised to observe a higher mortality of Dicerd/d mice upon
MCMV challenge (Fig. 4A). The difference in survival rate
between Dicerd/d and control mice was statistically significant
(p = 0.0429), but the phenotype clearly diverges from that which is
observed in BALB/c mice, which as opposed to C57BL/6 mice,
are highly susceptible to MCMV infection due to a mutation in the
Table 2. List of miRNAs strongly affected by the mutation in
Dicerd/d splenocytes.
Mature ID Fold Regulation
miR-135b 22.6965
miR-363 22.5995
miR-98 22.543
miR-132 22.355
miR-103 22.1776
miR-99b 22.044
miR-135a 21.8734
let-7d 21.7861
miR-130a 21.6538
miR-152 21.6246
miR-129-5p 21.6232
miR-298 21.6169
miR-185 21.6035
miR-214 21.5746
miR-140 21.5688
miR-134 21.5667
miR-18b 21.5607
miR-194 21.5509
let-7f 21.5107
miR-149 21.51
doi:10.1371/journal.pone.0043744.t002
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NK cell receptor ly49H [22,23]. We therefore suspected a subtly
deregulated antiviral response in the mutant, rather than a lack of
virus detection. Using absolute viral DNA quantification, we noted
increased MCMV replication in Dicerd/d splenocytes (Fig 4B). To
gain more insight into the potential defective response of Dicerd/d
mice to MCMV infection, we characterized and compared their
anti-MCMV response to that of control animals. First, we
quantified IFN-b in the serum of MCMV-challenged controls
and Dicerd/d mice. As illustrated in Fig. 4C, at 36 hours post-
infection (hpi), IFN-b secretion was significantly diminished in the
blood of mutant mice. We next monitored NK cell response, the
integrity of which is mandatory for effective viral clearance. In line
with the lower IFN-b production, we observed less (IFN-c +) NK
cells in the spleens of infected Dicerd/d mice than in wt mice at
3 days post infection (dpi) (Fig. 4D), reflecting a slightly impaired
NK cell response.
In a parallel experiment, we performed intraperitoneal injec-
tions of Dicerd/d and Dicer+/+ mice with a recombinant luciferase-
expressing MCMV. Using appropriate imaging equipment to
visualize light emission, we were able to follow viral replication in
vivo. We observed that, one day after viral inoculation, Dicerd/d
mutants seemed to control the infection more effectively than
controls (Fig. 4E). This is likely due to the moderate, but
constitutive overexpression of IFN-responsive genes in these
animals. However at day 4, mutants exhibited a striking
hypersusceptible phenotype characterized by higher viral load
compared to wild-type animals. We also performed a time-course
analysis of the luminescence produced by the virus in the infected
mice to further quantify these observations (Fig. 4F).
These data most probably reflect a complex situation in which
the maturation of both cellular and viral miRNAs is affected by the
mutation. Furthermore, the development of an effective antiviral
response requires the construction of a network of immune cells
Figure 3. Increased protein expression of putative miRNA-targeted genes in Dicerd/d mutants. A. CXCL10 was quantified in the serum of
naı¨ve controls (black dots) and Dicer mutant mice (white dots). B. CXCL10 (expressed in picograms for 16106 cells) quantification in the supernatant
of macrophages harvested from wild-type (+/+) and Dicerd/d mutants. C. STAT1 expression visualized by Western blot performed on spleen extracts
from two control animals and two Dicerd/d mutant mice. GAPDH serves as loading control. D. Quantification of STAT1 signals in spleen protein
extracts normalized to GADPH was done for 3 controls and 4 mutants. E. Sequence alignment of murine miR-21 and its target sequence in the Cxcl10
3’UTR. The mutated nucleotides disrupting miR-21 binding in the mutated Cxcl10 3’UTR are shown in red. F. miR-21 expression is reduced in Dicer d/
d splenocytes compared to wild-types. qRT-PCR was used to quantify miR-21 expression in wild-type and Dicerd/d splenocytes. G. Normalized
Luciferase expression (RLU) in HeLa cells. Control or anti-miR-21 (@miR-21) tiny LNAs were incubated with HeLa cells for 24 h. Afterward, cells were
transfected with empty vector (psiCHECK-2), or vectors containing a perfect match for miR-21 (PM21), the wild-type Cxcl10 3’UTR, or a mutated
Cxcl10 3’UTR downstream of the f-luc gene.
doi:10.1371/journal.pone.0043744.g003
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such as macrophages, dendritic cells, and NK cells interconnected
by a large panel of cytokines and chemokines (i.e, IL-12, IL-15,
Type I IFN, etc), which makes it difficult to tackle the precise
origin of this increased viral susceptibility.
6. Ex vivo infections confirm that cell-autonomous miRNA
defect increases susceptibility to MCMV
To decipher in more detail the molecular defects leading to
increased MCMV susceptibility of Dicer-deficient animals, we
turned to thioglycolate-elicited peritoneal macrophages, which
represent a convenient source of semi-purified MCMV-permissive
cells. As seen in Fig. 5A, peritoneal macrophages isolated from
Dicerd/d mice cannot efficiently control viral replication, as the
amount of MCMV genomes/cell is notably increased in these
cells. To confirm these data, we turned to a model of conditional
ablation of Dicer in macrophages. For this, peritoneal cells isolated
from transgenic mice (in which the Dicer gene is surrounded by
Lox-P sites, [24]) were infected with a CRE-recombinase-
expressing recombinant MCMV [14]. As seen in Fig. 5B, seven
and thirteen days post infection with the recombinant virus,
cellular miR-16 expression was diminished (1.9-fold at day 7 and
2.6-fold at day 13) reflecting the expected defect in miRNA
Figure 4. Dicerd/d mice are hypersusceptible to acute MCMV infection. A. Survival curve of control mice (+/+, black spots), Dicerd/d (white
spots) and BALB/c animals (black squares) upon acute MCMV infection (56105 pfu/mouse). B. Absolute quantification of the MCMV genome by qPCR
in infected wild-type mice (+/+) and Dicerd/d mutants. C. IFN-b quantification by ELISA in the serum of controls (+/+) and mutants 36 hours post-
infection (h.p.i). D. Quantification of activated NK cells (NKp46+/IFN-c+) in the spleen of non-infected (NI) and infected controls (+/+) and Dicer d/d
mice 72 h.p.i. 6 animals/group were used. E. Snapshot images showing MCMV-derived luminescence 1 (D1) and 4 days (D4) upon MCMV-Luc
infection of controls (+/+) and Dicerd/d mice. F. Time-course analysis of the luminescence quantification in MCMV-Luc infected controls (n = 6 +/+;
black spots) and mutants (n = 5; dotted line and white spots).
doi:10.1371/journal.pone.0043744.g004
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maturation. Concomitant increase of the precursor form (pre-
miR-16) was also observed (data not shown). Interestingly, viral
miR-23-2 production can still proceed, which indicates that the
remaining DICER is sufficient to process newly expressed
miRNAs. To quantify the efficacy of Dicer ablation using this
system, we used a PCR-based assay, which permits the simulta-
neous detection of the excised and non-excised alleles. Fluores-
cence quantification of the bands visualized on the gel was plotted
in Fig. 5C. It appears that under such conditions of infection
(multiplicity of infection (MOI) = 1), recombination at the Dicer
locus is limited (40% efficiency), and reaches its maximum efficacy
between day 12 and 16. Improved efficiency was obtained upon
infection at an MOI of 10 (data not shown). Nevertheless, under
these conditions of partial Dicer mRNA reduction, we also found
that MCMV replication is uncontrolled, as viral particle produc-
tion, quantified by plaque assay, is increased in Dicer-deficient
compared to wt cells (5- to 10-fold at 12 and 16 dpi) (Fig. 5D).
Altogether, these data indicate that the reduction of Dicer
expression in isolated cells affects MCMV replication. Such a
cell-autonomous phenotype demonstrates that the increased viral
susceptibility observed in vivo is not only the result of an impaired
immune response, but that other essential mechanisms such as
DNA replication control and the production of antiviral proteins
are also likely to play a key role.
7. Macroarray analysis of IFN-regulated genes in MCMV-
infected controls and Dicer-deficient cells suggests the
importance of repressor release
Next, we searched for molecular defects that might account for
the increased MCMV susceptibility of Dicer deficient animals. To
this end, we performed a PCR macroarray analysis to monitor the
effect of the Dicerd/d mutation on the expression of IFN-regulated
genes following MCMV infection. We first analyzed the expres-
sion of genes in the IFN pathway in the spleen of animals at 3
d.p.i. As expected, we observed that in wild-type animals many
(40/84) genes were induced upon MCMV infection (Fig. 6A),
whereas in Dicerd/d mice the MCMV response appears to be
globally deregulated (Fig. 6B). We validated these observations
using qRT-PCR and confirmed that MCMV-induced genes such
as Irf7, Ifit1 and Oas1a are significantly reduced in Dicer deficient
Figure 5. Ex vivo infected macrophages harvested from Dicer-deficient mice exhibit antiviral defects. A. Absolute quantification by qPCR
of the MCMV genome in control (+/+, black bars) macrophages and cells isolated from Dicerd/d mice (white bars) at different time points post
infection (p.i). B. Northern blot experiments showing, miR-16 and MCMV miR-M23-2 expression in peritoneal macrophages isolated from Dicerflox/flox
mice 7 days and 13 days upon MCMV-Cre infection. Numbers below miR-16 panel indicate relative expression. Controls (Ctrl) are mock-infected
macrophages. U6 expression serves as loading control. C. Quantification of Dicer excision efficacy upon MCMV-Cre infection of Dicer-floxed
macrophages. Intensity of bands corresponding to excised and non-excised alleles was measured from agarose gels. Ratio is plotted for days 8, 12
and 16. D. Increased viral replication in Dicer-floxed macrophages upon MCMV-Cre infection. MCMV titer was measured by plaque assay in the
supernatant of MCMV-Cre infected macrophages harvested from controls (+/+; dark spots) and Dicerflox/flox mice (white spots).
doi:10.1371/journal.pone.0043744.g005
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conditions (Fig. 6C-E). These results were confirmed with
peritoneal macrophages isolated from control and mutant mice
(Fig. S2). At the protein level, the expression of MCMV-induced
CXCL10 in the serum of infected Dicerd/d mice was significantly
reduced compared to wild-type animals (Fig. 6F). Similarly, the
expression of MCMV-dependent IRF7 is diminished in protein
extracts from Dicer mutant spleens compared to wt (Fig. 6G).
Globally, the picture emerging from our data (Fig. S3) indicates
that in spleen and primary macrophages isolated from Dicerd/d
mice, IFN-stimulated gene expression induced by MCMV
infection is reduced. This indicates that, in the tight balance
between repressors and activators that govern the efficient control
of gene expression, a miRNA-dependent control of repressors
could be an important facet of the transcriptional control of IFN-
stimulated gene expression.
Because gene responses following acute viral (including MCMV)
infection strongly depend on the activation of Toll-like Receptors
(TLRs) [11,12], a miRNA-dependent modulation of these factors
might explain the above-described phenotype. However, we were
unable to detect any significant decrease in type I IFN response
Figure 6. IFN-stimulated genes induction is impaired in MCMV-infected Dicerd/d mice. A. Scatterplot shows multiple IFN-dependent genes
up-regulation (red dots) in MCMV-infected control mice (+/+). B. Scatterplot analysis comparing MCMV-infected controls (+/+) and Dicerd/d mice. C–E.
qRT-PCR data on selected MCMV-inducible genes (Irf7, Ifit1 and Oas1a). The graphs show relative gene expression in controls (black spots; +/+) and
Dicerd/d (white spots) spleen extracts. F. CXCL10 was measured in the serum of controls (white dots, +/+) and Dicerd/d mice (black dots) 36 hours p.i. G.
IRF7 expression was analyzed by Western blot performed on protein extracts from MCMV-infected wild-type (+/+) and mutant mice. GAPDH
expression serves a loading control.
doi:10.1371/journal.pone.0043744.g006
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after stimulation of wt and Dicerd/d macrophages with several
TLR ligands (data not shown).
Going more into the details of each gene present on the array,
we observed that the transcriptional response to MCMV infection
in primary macrophages is highly homogenous with one group of
genes going down in mutant cells and the other remaining
constant. In fact, we only observed two exceptions to this
classification at 24 h post-infection: Psme2 (more induced in
mutants than in controls), and Samsn1 (repressed in controls, and
unaffected in mutant cells). Despite these two marginal cases, these
experiments clearly indicate that Dicer reduction provokes a
highly significant (p,0.0001, calculated at 24 h and 72 h post-
infection, see Fig. S3) global 2-fold decrease in the expression of
IFN-stimulated genes. Similar conclusions can be drawn from the
analysis of whole spleens.
8. Profiling of cellular and viral miRNAs upon MCMV
infection
To complete our analysis, we measured by PCR array the
expression of miRNAs associated with inflammation/immunity
upon MCMV infection of mice or peritoneal macrophages. In
these two experiments, the results of the macroarray enable
important observations. We found that several miRNAs were
induced by MCMV in splenocytes of control mice (not shown).
Among these upregulated miRNAs are miR-155 (4.3-fold), a well
described actor in inflammatory reactions [25], and the TLR-
dependent miR-147 (8-fold) [26], which has also been recently
shown to be involved in the response to dengue virus [27]. In
accordance with our repressor hypothesis described above, it is
tempting to speculate that these MCMV-induced miRNAs could
target repressor genes, thus permitting a rapid increase in IFN-
stimulated gene expression. In Dicer mutant splenocytes, the
induction of these miRNAs is impaired, which might lead to
augmented repressor activity, and thus a diminished IFN response.
We also note with interest that MCMV infection leads to the
downregulation of certain miRNAs (miR-135b and miR-145
exhibit respectively 3.5-fold and 4.9-fold reduction), suggesting
viral control of cellular miRNA production.
In MCMV-infected Dicerd/d peritoneal macrophages, we
observed that although some miRNAs are induced, there is a
highly significant decrease in the expression of certain miRNAs
(Fig. S4). A quantification of this decrease (Fig. S4B) shows that
the overall fold change is 0.26 in controls vs. 21.3 in Dicerd/d
macrophages (p,0.0001).
Finally, we also quantified by qRT-PCR 16 out of 18 MCMV-
encoded miRNAs in spleens of MCMV-infected controls and
Dicer-deficient mice. Ten viral miRNAs (62.5%) exhibited
significantly reduced expression in mutant splenocytes (Fig. 7).
Surprisingly, the expression of mcmv-miR-m59-2 and miR-m87-1
appeared augmented in splenocytes isolated from Dicerd/d mice.
However, this seems to be due to a specificity issue since we also
detected expression of miR-m59-2 in uninfected spleen cells (data
not shown). Similar to our previous observations for cellular
miRNAs, certain viral miRNAs (e.g. miR-m01-3 and m01-4) are
expressed at the same level in wild-type and mutants. This asks the
question as to the constraints that are required at the pre-miRNA
level for Dicer maturation.
Discussion
1. In vivo identification of functional miRNA/mRNA-
targeted genes
As opposed to classical approaches where miRNA target
predictions lead the way to identify relevant miRNA-target pairs,
we chose here to analyze the phenotype of Dicer mutants to
identify potential miRNA targets, and then, to use in silico analyses
and reporter-based assays for confirmation. As an illustration of
this procedure, Cxcl10 was selected because altered expression of
this chemokine is associated with inflammatory defects and viral
susceptibility [28]. By inhibiting the endogenous human miR-21
(which is 100% identical to the Mus musculus ortholog) in Hela cells,
we found that the expression of CXCL10 was regulated by this
miRNA (Fig. 3). Interestingly, we noticed the occurrence of 2
SNPs (rs8878 and rs3921) that may affect miRNA binding
sequences in the human Cxcl10 3’UTR, as predicted by a new
web-based tool, MicroSNiPER [29]. Furthermore, we observed
miR-21 induction in controls compared to MCMV-infected
splenocytes (2.3 fold) and macrophages (1.8 fold). However,
similar induction rates were obtained in tissues harvested from
Dicer mutant animals upon viral infection.
Many reports have described the influence of viral infection on
individual cellular miRNA expression (reviewed in [4]). Our effort
to concur in a wider description of miRNA involvement in host-
pathogen interactions is in agreement with previous data showing
up-regulation of cellular miRNAs such as miR-155 and miR-147,
which are involved in the control of inflammatory responses
[25,26]. But our microarray analysis unveils additional miRNAs
that may be essential modulators of this process in acute MCMV
infection. Indeed, miR-182, miR-183 and miR-31 are strongly
induced upon MCMV in vivo infection, and interestingly two of
these, miR-182 and 183 are also induced upon human CMV
infection of fibroblasts [30]. In addition, the same set of miRNAs
was shown to be overexpressed in splenocytes of Lupus-prone
mice [31], which is in agreement with our model predicting that
these miRNAs might target transcriptional repressors of IFN-
stimulated genes.
It would be of interest to perform a thorough analysis of the
promoters of MCMV-inducible miRNAs to identify potential
IFN-responsive elements. This would then allow the reconstitution
of a complex network of interactions between miRNAs and viral
infection.
2. Induction of IFN-dependent genes upon viral infection
requires repressor release
Although the protective role of type I IFN against viral
infections has been intensively studied for decades [32,33], a
thorough understanding of the transcriptional program engaged
upon viral infection is far from complete. It is now well established
that the panel of IFN-stimulated genes (ISGs) is both cell and virus
dependent, which illustrates the complexity of the so-called ‘IFN
response’. Here, we addressed the potential role of miRNAs in the
control of IFN-dependent, MCMV-regulated genes. As schema-
tized in Fig. 8A, we observe a Dicer-dependent increase in IFN-
response gene expression under naive conditions, whereas the
opposite was observed in MCMV infected samples. Given the
inhibitory effect of miRNAs, we suggest that miRNAs limit the
level of transcriptional activators under steady-state conditions to
ensure repressor dominance, thus preventing leakage of ISGs that
could trigger adverse reactions (Fig. 8B). As inferred from our
data, STAT1 is a likely miRNA-dependent activator (Fig. S1) and
we are currently testing this hypothesis. We also keep in mind that
miRNAs could indirectly impact upon the expression of Interfer-
on-responsive genes. For instance, transcription elongation PAF1,
which selectively mediates antiviral genes response [34] could also
be under miRNA-dependent regulation.
Next, our model also predicts that following viral infection
miRNA-dependent repressor release from target genes enables
rapid gene activation, but upon low miRNAs conditions in Dicerd/d
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mice, such repressors (e.g TRIM28 [35]) are overexpressed, hence
the lower IFN response. An efficient and harmless for the host
antiviral program requires tight control of the inflammatory
response. This has been demonstrated in the case of TLR-
dependent TNF-a synthesis in which repressors such as IRAK-M
or SOCS1 [36] appear essential in the post-induction turn-off.
Similarly, Type I IFN-dependent expression must also be under
strict fine-tuning, but the underlying mechanisms are still largely
unknown [37].
In addition, our macroarray analysis provides a unique and
comprehensive picture of IFN-dependent gene induction upon
MCMV infections. These data confirmed the importance of
master factors such as IRF7, which is strongly induced by MCMV
both in vivo and ex vivo. Interestingly, we also noted MCMV-
dependent down modulation of several genes (i.e. Irf2, Irf3, Irf5),
which reveals potential virus hijacking. Recent demonstration that
Kaposi’s sarcoma herpesvirus encodes a viral IRF3 that inhibits
cellular IRF5 strengthens this suggestion [38].
3. miRNA: antiviral players in vertebrates? What our
model teaches us
An important objective of our work was to measure the
importance of miRNAs as defensive tools against MCMV
infection. A large amount of data has demonstrated that Dicer
targeted inactivation impairs immune functions, but a global in vivo
evaluation of the roles of miRNAs in antiviral defense in a relevant
and authentic animal model had so far not been reported. A
previous report had described increased susceptibility to VSV
infection in Dicer mutant mice [6]. However, a major weakness of
this model was its lack of physiological relevance, since VSV is not
a natural pathogen of mice. To circumvent these restrictions, we
analyzed IFN-stimulated genes and inflammation/immunity-
related miRNA expression in Dicer-deficient mice, both in naive
conditions and upon acute MCMV infection. We also focused on
herpesviruses because these pathogens express their own set of
miRNAs. The existence of these molecules, likely hijacked by
viruses for their own benefit, is suggestive that the miRNA
machinery actively participates in innate antiviral responses.
Indeed, MIC-B is targeted by HCMV-derived miRNAs, which
Figure 7. Dicerd/d mutation affects the expression of a subset of MCMV-encoded miRNAs in macrophages. Virally-derived miRNAs were
quantified by qRT-PCR in MCMV-infected macrophages harvested from control (dark bars, +/+) or Dicerd/d mutant mice (light grey bars).
doi:10.1371/journal.pone.0043744.g007
Figure 8. Model for miR-dependent control of IFN-regulated
genes. A. Schematic representation of our macroarray data. Interferon-
stimulated genes (ISG) expression is indicated for controls (+/+, dark
grey) and Dicerd/d (light grey) cells in naı¨ve or MCMV-stimulated
conditions. B. In naı¨ve control (+/+) cells, repression of ISGs is secured
by miRNA-mediated repression exerted on transcriptional activators (in
blue); on the contrary, rapid induction of ISGs upon virus (depicted in
green) infection is permitted by MCMV-induced miRNA-mediated
release of repressors (in red) along with virally-induced transcriptional
induction of activators.
doi:10.1371/journal.pone.0043744.g008
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allow the pathogen to escape NK-cell-mediated killing [39]. Our
own data somehow contradict this model in which viral miRNAs
would be considered as pathogenicity factors. Indeed, we observe
lower survival in Dicer-deficient animals (Fig. 4), whereas
diminishing viral miRNA maturation would expect to decrease
MCMV pathogenicity. On the other hand, Dicer d/d mutant mice
are also characterized by diminished cellular miRNAs synthesis,
which lowers inflammatory response upon MCMV infection,
hence increasing host susceptibility. It is therefore difficult to weigh
the exact contribution of pathogenic viral miRNAs vs. protective
cellular miRNAs in our complex in vivo model, but our survival
data nevertheless suggest that cellular miRNAs prevail over viral
molecules. This observation may have important repercussions in
human health, where null mutants are unlikely, but variable
DICER levels in the population could account for differences in
susceptibility to pathogens among individuals.
Finally, our in vivo approach in mice indicates that Dicer
reduction induces only limited viral susceptibility compared to
mutants affecting IFN signaling, as noted previously [40]. This
contrasts with the situation in plants [41] or Drosophila [42],
whose defense mechanisms rely solely on RNA interference, and
in which severe phenotypes appear under viral infection of Dicer
mutants. Therefore, our in vivo data suggest that a fine-tuned IFN
response to a viral pathogen in vertebrates requires a carefully
balanced arsenal of cellular miRNAs.
Supporting Information
Figure S1 STAT1-dependent genes are induced in
Dicerd/d mice. The difference in gene expression (fold
regulation) between control and Dicerd/d splenocytes was measured;
genes were separated according to the presence of STAT1-binding
motifs in their promoters. ** p = 0.0016.
(TIF)
Figure S2 Dicerd/d mutation impairs IFN-stimulated
genes induction upon MCMV infection of isolated
macrophages. A. Scatterplot showing relative gene expression
between non-infected (NI) and MCMV-stimulated macrophages
from wild-type (+/+) mice. B. Scatterplot showing relative gene
expression between MCMV-infected macrophages from control
(+/+) mice compared to cells harvested from Dicerd/d animals. C-E.
RT-qPCR data showing lower expression of selected genes (irf7,
Oas1a and Isg20) in cells isolated from Dicerd/d mice compared to
macrophages from controls (+/+).
(TIF)
Figure S3 Dicerd/d mutation impairs IFN-stimulated
genes induction upon MCMV infection; statistical anal-
ysis. A. Histogram showing relative expression of IFN-dependent
genes (fold change between non-infected vs. MCMV-stimulated) in
macrophages from controls (black bars) and Dicerd/d (white bars)
mice 24 hours p.i. B. Similar analysis performed 72 hours p.i. C.
Similar analysis performed in splenocytes 3 days upon in vivo
MCMV infection of mice.
(TIF)
Figure S4 miRNAs expression is strongly reduced in
MCMV-infected macrophages harvested from Dicerd/d
mice. A. Pie chart representing the proportion of overexpressed
(green), repressed (blue) and unaffected miRNAs involved in
immunity/inflammation in MCMV-stimulated control (+/+)
macrophages and Dicerd/d mutants. B. Histogram showing relative
expression (Fold change between naı¨ve and MCMV-infected) of
miRNAs in control (+/+, dark bar) and Dicerd/d (light grey bar)
macrophages.
(TIF)
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